Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05682209

The Effect of Octreotide on Wound Drainage After Mastectomy

Conditions: Seroma Following Procedure

Sex: Female
Phase: PHASE4
Enrollment: 41
Sponsor: Ikechukwu Bartholomew Ulasi

Location: Nigeria

Summary

Patients who had mastectomy for breast cancer usually have drainage of some fluid from the site of surgery. This could be prolonged and may lead to other negative consequences after surgery. Octreotide could potentially reduce the amount of this drainage. In this study, patients were grouped into two: a first group that received octreotide injection and a second group that received a placebo. The study tested whether octreotide injection has any effect on the duration of fluid drainage from the surgery site after mastectomy for breast cancer.

Eligibility Criteria

Inclusion Criteria:All female breast cancer patients requiring modified radical mastectomyExclusion Criteria:All mastectomies without axillary clearance (simple and toilet mastectomies)Breast-conserving surgeriesPatients undergoing immediate breast reconstruction after mastectomyPrevious axillary surgery

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05682209). StuddyBuddy aggregates publicly available trial information.